Imagion Biosystems receives order related to cancer treatment

Matthew Wygant Investor Updates, News

Imagion Biosystems today announced that NewPhase Ltd., an Israeli biotechnology company developing cancer treatments, has issued an extended purchase order to Imagion Biosystems for the supply of nanoparticles for the remainder of 2019 to be used in the NewPhase product.

View the entire announcement here.